Pictet Asset Management
VIR icon

Pictet Asset Management’s Vir Biotechnology VIR Stock Holding History

Pictet Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
1,953,316
+472,488
+32% +$4.5M 0.02% 535
2026
Q1 		$13.3M Buy
1,480,828
+1,467,340
+10,879% +$11.7M 0.01% 585
2025
Q4 		$81.3K Hold
13,488
– – ﹤0.01% 2043
2025
Q3 		$77K Hold
13,488
– – ﹤0.01% 2003
2025
Q2 		$68K Hold
13,488
– – ﹤0.01% 1975
2025
Q1 		$87.4K Buy
+13,488
New +$120K ﹤0.01% 1947

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pictet Asset Management's VIR Position: Q2 2026 in Review

Pictet Asset Management increased its Vir Biotechnology (VIR) stake by 32% in Q2 2026, buying an estimated $4.5M and bringing the position to 1,953,316 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #535.

Pictet Asset Management first reported a position in VIR in Q1 2025 and has held it in 6 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Pictet Asset Management held 1,953,316 shares of Vir Biotechnology worth $19.9M as of Q2 2026.
  • Pictet Asset Management bought 472,488 Vir Biotechnology shares in Q2 2026, an estimated $4.5M.
  • Vir Biotechnology made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #535 holding.
  • Pictet Asset Management first reported a position in Vir Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.